To use all functions of this page, please activate cookies in your browser.
my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Homatropine
Homatropine (Equipin®, Isopto Homatropine®) is an anticholinergic medication that inhibits muscarinic acetylcholine receptors and thus the parasympathetic nervous system. It is used in eye drops as a cycloplegic, to temporarily paralyze accommodation, and as a mydriatic, to dilate the pupil. Additional recommended knowledgeHomatropine is less potent than atropine and has a shorter duration of action. It is available as the hydrobromide or methylbromide salt. Drugs like hydrocodone are mixed with small amounts of an anticholinergic such as homatropine methylbromide to discourage abuse. Homatropine is also given as an atropine substitute given to reverse the muscarinic and CNS effects associated with indirect cholinomimetic (anti-AChase) administation. Side effects
Contraindications
|
||||||||||||||||||||||||||||||||||||||||||||||||
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Homatropine". A list of authors is available in Wikipedia. |
- Immunohistochemistry
- LifeScan
- H-TEC SYSTEMS and Bilfinger cooperate to drive efficient green hydrogen projects in Europe - Strategic partnership with focus on large-scale electrolysis
- Robert_Thompson_Crawshay
- BASF and Nanotech Energy partner for lithium-ion batteries with locally recycled content in North America - BASF will be the first company in North America to provide cathode active materials produced with recycled metals on a commercial scale starting in 2024